Cassiopea: Rallies on FDA approval for acne treatment

Cosmo NV

27/08/2020 08:27

** Shares in Cassiopea  SKIN.S  jump 7.6% to more than
1-year high after the Swiss drugmaker gets U.S. FDA approval for
acne treatment Winlevi  urn:newsml:reuters.com:*:nL8N2FT0ON
    ** Jefferies sees Winlevi to be a highly profitable
opportunity either as a stand-alone asset or as part of a
broader commercial portfolio
    ** Cassiopea's biggest shareholder Cosmo Pharmaceuticals
 COPN.S  rises 3.2%

 ((elizaveta.gladun@thomsonreuters.com))